Found: 20
Select item for more details and to access through your institution.
Enzalutamide shows sustained overall survival improvement in patients with metastatic hormone‐sensitive prostate cancer.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 15, p. 2278, doi. 10.1002/cncr.34910
- By:
- Publication type:
- Article
Talazoparib for newly diagnosed prostate cancer associated with significant risk reduction of disease progression.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 15, p. 2277, doi. 10.1002/cncr.34909
- By:
- Publication type:
- Article
First person profile: Anil K. Rustgi, MD: Dr Rustgi has spent his career collaborating with a variety of researchers to address wide‐ranging problems in cancer treatment.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 15, p. 2276, doi. 10.1002/cncr.34908
- By:
- Publication type:
- Article
ChatGPT—A promising generative AI tool and its implications for cancer care.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 15, p. 2284, doi. 10.1002/cncr.34827
- By:
- Publication type:
- Article
Mitotic rate in primary cutaneous melanoma: Cell division matters.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 15, p. 2290, doi. 10.1002/cncr.34825
- By:
- Publication type:
- Article
The prognostic role of mitotic rate in cutaneous malignant melanoma: Evidence from a multicenter study on behalf of the Italian Melanoma Intergroup.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 15, p. 2331, doi. 10.1002/cncr.34824
- By:
- Publication type:
- Article
Safety of loncastuximab tesirine‐lpyl in diffuse large B‐cell lymphoma with severe hepatic dysfunction.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 15, p. 2279, doi. 10.1002/cncr.34816
- By:
- Publication type:
- Article
Detection of multiple types of cancer driver mutations using targeted RNA sequencing in non–small cell lung cancer.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 15, p. 2422, doi. 10.1002/cncr.34804
- By:
- Publication type:
- Article
RNA sequencing steps toward the first line.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 15, p. 2294, doi. 10.1002/cncr.34801
- By:
- Publication type:
- Article
Phase 1/1b study of azacitidine and hedgehog pathway inhibitor sonidegib in patients with myeloid neoplasms.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 15, p. 2321, doi. 10.1002/cncr.34800
- By:
- Publication type:
- Article
High serum magnesium is associated with lower risk of hepatocellular carcinoma among patients with nonalcoholic fatty liver disease.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 15, p. 2341, doi. 10.1002/cncr.34799
- By:
- Publication type:
- Article
Neighborhood attributes and cardiovascular disease risk in breast cancer survivors: The Pathways Study.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 15, p. 2395, doi. 10.1002/cncr.34794
- By:
- Publication type:
- Article
First‐in‐human study of E7130 (a tumor microenvironment‐ameliorating microtubule inhibitor) in patients with advanced solid tumors: Primary results of the dose‐escalation part.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 15, p. 2348, doi. 10.1002/cncr.34788
- By:
- Publication type:
- Article
Plasma levels of interleukin‐6 mediate neurocognitive performance in older breast cancer survivors: The Thinking and Living With Cancer study.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 15, p. 2409, doi. 10.1002/cncr.34784
- By:
- Publication type:
- Article
Prevalence of oral and blood oncogenic human papillomavirus biomarkers among an enriched screening population: Baseline results of the MOUTH study.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 15, p. 2373, doi. 10.1002/cncr.34783
- By:
- Publication type:
- Article
Vimentin expression correlates with immune checkpoint inhibitor efficacy in non–small cell lung cancer.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 15, p. 2297, doi. 10.1002/cncr.34782
- By:
- Publication type:
- Article
Entospletinib with decitabine in acute myeloid leukemia with mutant TP53 or complex karyotype: A phase 2 substudy of the Beat AML Master Trial.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 15, p. 2308, doi. 10.1002/cncr.34780
- By:
- Publication type:
- Article
Short‐term and long‐term effect of nutrition intervention in the Linxian Dysplasia Nutrition Intervention Trial and the reason for disappearance of the intervention effect: A cohort study.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 15, p. 2360, doi. 10.1002/cncr.34761
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 15, p. 2269, doi. 10.1002/cncr.33721
- Publication type:
- Article
Tobacco use and cancer‐related symptom burden: Analysis of the US Population Assessment of Tobacco and Health Study.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 15, p. 2385, doi. 10.1002/cncr.34746
- By:
- Publication type:
- Article